Developer docs
API playgroundTry for free, no card

Search company profiles

Ebba Biotech AB

Full company profile

uuid000fxvt

Namestring
Ebba Biotech AB
Legal namestring
Ebba Biotech AB
Websiteurl
ebbabiotech.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Ebba Biotech AB is a privately held Swedish biotechnology company founded in 2016 and headquartered at the Karolinska Institutet Science Park in Solna, Sweden. The company develops and commercializes luminescent conjugated oligothiophene (LCO) fluorescent tracer molecules, branded as "optotracers," which fluoresce only when bound to specific biological targets. Its portfolio spans three core product lines: Amytracker (amyloid and protein aggregate detection in tissue, cells, and in vivo models), EbbaBiolight (bacterial extracellular matrix and biofilm visualization), and Carbotrace (non-destructive carbohydrate and glucan analysis for plant biomass research). Each line is offered in five spectral variants (480-680 nm) and multiple formulations including aqueous, DMSO, solid (for IV injection), and ready-to-use Drop&Shine mounting media. A complementary Carbotrace Testing Service provides laboratory-based carbohydrate analysis for customers seeking guidance on product selection.

The company sells directly through its e-commerce storefront and via a global distributor network reaching 40+ countries, with a documented customer mix of 37% academia, 31% industry, and 32% distributors. Pricing is transparent and modest, ranging from EUR 200 for individual Amytracker variants to EUR 500 for Mix&Try bundles and EUR 2,000 for premium listings. Marketing relies heavily on scientific credibility, supported by 120+ peer-reviewed publications and 30+ papers in 2025 alone, rather than paid advertising. Ebba Biotech maintains deep institutional ties with Karolinska Institutet through co-founder Ferdinand X. Choong (Assistant Professor and AIMES Team Leader) and Founder/Chairman Prof. Agneta Richter-Dahlfors, and has cultivated commercial partnerships with Inscopix (miniscope integration), reMYND/InnoSer (CRO protocol adoption), and Cytacoat AB (anti-fouling catheter coatings). With 1-10 employees and no disclosed external funding, Ebba Biotech operates as a lean, research-tools supplier whose growth depends on publication-driven adoption and distributor-led geographic expansion.

Short descriptiontext

Ebba Biotech AB is a Swedish biotech company that develops and sells fluorescent optotracer molecules (Amytracker, EbbaBiolight, Carbotrace) for detecting amyloid protein aggregates, bacterial biofilms, and plant carbohydrates, serving academic researchers, CROs, and industry in 40+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSolna, Sweden
HQ citystring
Solna
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fluorescent optotracer dyes, amyloid detection reagents, biofilm imaging probes, carbohydrate analysis tools, neurodegenerative research reagents
Industry3 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Life Science Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Product sales - Amytracker, EbbaBiolight, Carbotrace
TypeOne Time License
Description

Sale of fluorescent optotracer reagents in multiple formulations (aqueous, DMSO, solid, Drop&Shine) and spectral variants (480, 520, 540, 630, 680 nm peak emission). Products sold directly via e-commerce and through global distributors. Mix&Try bundled products available at 500 EUR.

ebbabiotech.com
2Carbotrace Testing Service
TypeProfessional Services
Description

Laboratory testing service for carbohydrate analysis using Carbotrace optotracer technology, providing spectrophotometric analysis and data interpretation for customers who need assistance determining the best Carbotrace molecule for their analysis.

ebbabiotech.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details2 tiers
1Amytracker Mix&Try bundle
ModelUnit PricingBilling cadencePay-as-you-go
Notes

500 EUR - bundle of multiple Amytracker variants for evaluation purposes

ebbabiotech.com
2Amytracker 680 - single variant
ModelUnit PricingBilling cadencePay-as-you-go
Notes

From 200 EUR - multiple formulation options (Aqueous, DMSO, Solid, Drop&Shine) at varying price points

ebbabiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Amytracker
Description

Fluorescent tracer molecules for detection of protein aggregates suitable for fibrillation assays, fixed or fresh tissue sections, cells, and in vivo systemic injection. Available in five variants (480, 520, 540, 630, 680) specified by peak emission wavelength.

ebbabiotech.com
+2 more records
Core offering1 text field

Ebba Biotech AB develops and commercializes fluorescent optotracer reagents based on luminescent conjugated oligothiophenes (LCOs) for visualizing biological nanostructures in research applications. The portfolio comprises three product lines: Amytracker (protein aggregate/amyloid detection), EbbaBiolight (bacterial and biofilm imaging), and Carbotrace (carbohydrate analysis), sold in multiple spectral variants and formulations. A laboratory-based Carbotrace Testing Service is also offered to assist customers with sample analysis and product selection.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Amytracker is 10x brighter than Congo Red and detects amyloid in 15% of Congo Red negative samples
+1 more record
Product overview1 text field

Ebba Biotech AB develops and commercializes fluorescent optotracer molecules for visualizing nanostructures in biological research. The product portfolio consists of three core product lines: Amytracker for amyloid and protein aggregate detection, EbbaBiolight for bacterial biofilm visualization, and Carbotrace for carbohydrate/glucan analysis. The products are small fluorescent dye molecules that bind to specific biological targets and are used with fluorescence microscopy, plate readers, and other imaging equipment. A Carbotrace Testing Service is also offered to help researchers select the appropriate product variant for their needs.

Product and service1 record
1Amytracker
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ebba Biotech was co-founded by researchers from Karolinska Institutet. Co-founder Ferdinand X. Choong is Team Leader at AIMES, and founder Prof. Agneta Richter-Dahlfors is Professor at Karolinska Institutet. AIMES is a joint center funded by KTH Royal Institute of Technology and Karolinska Institutet, promoting interdisciplinary research. Multiple publications and testimonials cite research conducted at AIMES using Ebba Biotech products, indicating ongoing collaborative R&D relationship.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

reMYND is a Contract Research Organization that has integrated Amytracker 520 into its preclinical research protocols for Alzheimer's and Parkinson's disease mouse models. Their Science Director, Tom Cornelissen, provided a testimonial highlighting the exceptional results with Amytracker 520 for detecting pathological features in brain tissue.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Inscopix, a company developing miniaturized microscopes (nVista miniscope) for in vivo brain imaging, has incorporated Amytracker 520 into their platform. Senior Research Scientist Shan Huang provided a testimonial noting Amytracker 520's exceptional performance for labeling A-beta plaques in vivo in 5xFAD mice with high signal-to-noise and efficient blood-brain barrier crossing.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cytacoat AB, in collaboration with Karolinska Institutet and University of Southampton, used EbbaBiolight as part of research developing LubriShield, a novel anti-fouling coating for urinary catheters to prevent biofilm-related infections.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biotium (now part of Abcam) develops fluorescent dyes and probes for life science research, including protein aggregate and cell biology stains. It is a direct comparable in size, focus, and distribution model (e-commerce + distributors), making it the closest peer to Ebba Biotech's optotracer reagent business.

2Lumiprobe
TypeDirect peer
Description

Lumiprobe manufactures specialty fluorescent dyes for biology and diagnostics, including reactive dyes and protein labels sold through e-commerce globally. Comparable as a similarly-sized fluorescent-probe specialist with a similar online + distributor go-to-market.

3ATTO-Tec
TypeDirect peer
Description

ATTO-Tec develops high-performance fluorescent dyes used in microscopy, flow cytometry, and bioanalytics. Comparable as a specialty dye manufacturer targeting similar imaging and life-science research customers as Ebba Biotech.

4StressMarq Biosciences
TypeDirect peer
Description

StressMarq supplies amyloid reagents, recombinant proteins, and antibodies for neurodegeneration research. Directly comparable product overlap with Ebba's Amytracker line for Alzheimer's, Parkinson's, and prion research.

TypeDirect peer
Description

AnaSpec (now part of Eurofins) provides custom peptides, fluorescent probes, and amyloid research reagents. Direct overlap with Ebba Biotech's amyloid and protein-aggregate detection product line and similar customer base.

TypeBroad incumbent
Description

Thermo Fisher's Life Science Solutions division sells an extensive catalog of fluorescent reagents, amyloid stains, and protein-aggregate detection kits under the Invitrogen and Thermo Scientific brands. A broad incumbent with overlapping capabilities rather than a niche competitor.

TypeBroad incumbent
Description

Bio-Techne (including R&D Systems and Tocris) offers proteins, antibodies, and small-molecule probes for neuroscience and cell biology. Overlaps with Ebba Biotech through reagents targeting protein aggregation and neurodegenerative disease research.

TypeBroad incumbent
Description

Merck's life science division (Sigma-Aldrich, Millipore) distributes a broad catalog of fluorescent dyes, including thioflavin variants and Congo Red used as benchmark amyloid stains. Comparable as the dominant incumbent against whose legacy dyes Ebba Biotech competes.

TypeBroad incumbent
Description

Abcam, now part of Danaher, supplies antibodies and reagents for protein research, including antibodies targeting amyloid aggregates. Comparable as a broad incumbent serving the same academic and industry neuroscience customers as Ebba Biotech.

TypeBroad incumbent
Description

Li-Cor develops infrared fluorescent dyes and imaging systems for Western blots, microscopy, and in vivo imaging. Comparable as a specialty fluorescent-probe and imaging company with overlapping applications in protein-aggregate detection workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ebba Biotech AB

Life Science Reagentsebbabiotech.com

Ebba Biotech AB is a Swedish biotech company that develops and sells fluorescent optotracer molecules (Amytracker, EbbaBiolight, Carbotrace) for detecting amyloid protein aggregates, bacterial biofilms, and plant carbohydrates, serving academic researchers, CROs, and industry in 40+ countries.

What Ebba Biotech AB does

Ebba Biotech AB is a privately held Swedish biotechnology company founded in 2016 and headquartered at the Karolinska Institutet Science Park in Solna, Sweden. The company develops and commercializes luminescent conjugated oligothiophene (LCO) fluorescent tracer molecules, branded as "optotracers," which fluoresce only when bound to specific biological targets. Its portfolio spans three core product lines: Amytracker (amyloid and protein aggregate detection in tissue, cells, and in vivo models), EbbaBiolight (bacterial extracellular matrix and biofilm visualization), and Carbotrace (non-destructive carbohydrate and glucan analysis for plant biomass research). Each line is offered in five spectral variants (480-680 nm) and multiple formulations including aqueous, DMSO, solid (for IV injection), and ready-to-use Drop&Shine mounting media. A complementary Carbotrace Testing Service provides laboratory-based carbohydrate analysis for customers seeking guidance on product selection.

The company sells directly through its e-commerce storefront and via a global distributor network reaching 40+ countries, with a documented customer mix of 37% academia, 31% industry, and 32% distributors. Pricing is transparent and modest, ranging from EUR 200 for individual Amytracker variants to EUR 500 for Mix&Try bundles and EUR 2,000 for premium listings. Marketing relies heavily on scientific credibility, supported by 120+ peer-reviewed publications and 30+ papers in 2025 alone, rather than paid advertising. Ebba Biotech maintains deep institutional ties with Karolinska Institutet through co-founder Ferdinand X. Choong (Assistant Professor and AIMES Team Leader) and Founder/Chairman Prof. Agneta Richter-Dahlfors, and has cultivated commercial partnerships with Inscopix (miniscope integration), reMYND/InnoSer (CRO protocol adoption), and Cytacoat AB (anti-fouling catheter coatings). With 1-10 employees and no disclosed external funding, Ebba Biotech operates as a lean, research-tools supplier whose growth depends on publication-driven adoption and distributor-led geographic expansion.

Ebba Biotech AB firmographics

Firmographics
Name
Ebba Biotech AB
Legal name
Ebba Biotech AB
Website
https://ebbabiotech.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Ebba Biotech AB is a Swedish biotech company that develops and sells fluorescent optotracer molecules (Amytracker, EbbaBiolight, Carbotrace) for detecting amyloid protein aggregates, bacterial biofilms, and plant carbohydrates, serving academic researchers, CROs, and industry in 40+ countries.
Ownership category
akta.pro rank

Ebba Biotech AB industry classification

Industry
Product category
Life Science Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Fluorescent optotracer dyes
  • Amyloid detection reagents
  • Biofilm imaging probes
  • Carbohydrate analysis tools
  • Neurodegenerative research reagents

Where Ebba Biotech AB is headquartered

Location

Headquarters

HQ city
Solna
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Ebba Biotech AB business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Product sales - Amytracker, EbbaBiolight, Carbotrace: Sale of fluorescent optotracer reagents in multiple formulations (aqueous, DMSO, solid, Drop&Shine) and spectral variants (480, 520, 540, 630, 680 nm peak emission). Products sold directly via e-commerce and through global distributors. Mix&Try bundled products available at 500 EUR.
  2. Carbotrace Testing Service: Laboratory testing service for carbohydrate analysis using Carbotrace optotracer technology, providing spectrophotometric analysis and data interpretation for customers who need assistance determining the best Carbotrace molecule for their analysis.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goAmytracker Mix&Try bundle
Unit PricingPay-as-you-goAmytracker 680 - single variant

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Ebba Biotech AB product offering

Product offering

Core offering

Ebba Biotech AB develops and commercializes fluorescent optotracer reagents based on luminescent conjugated oligothiophenes (LCOs) for visualizing biological nanostructures in research applications. The portfolio comprises three product lines: Amytracker (protein aggregate/amyloid detection), EbbaBiolight (bacterial and biofilm imaging), and Carbotrace (carbohydrate analysis), sold in multiple spectral variants and formulations. A laboratory-based Carbotrace Testing Service is also offered to assist customers with sample analysis and product selection.

Product overview

Ebba Biotech AB develops and commercializes fluorescent optotracer molecules for visualizing nanostructures in biological research. The product portfolio consists of three core product lines: Amytracker for amyloid and protein aggregate detection, EbbaBiolight for bacterial biofilm visualization, and Carbotrace for carbohydrate/glucan analysis. The products are small fluorescent dye molecules that bind to specific biological targets and are used with fluorescence microscopy, plate readers, and other imaging equipment. A Carbotrace Testing Service is also offered to help researchers select the appropriate product variant for their needs.

Differentiator

Problem solved

Functional benefit

Brands

  • Amytracker: Fluorescent tracer molecules for detection of protein aggregates suitable for fibrillation assays, fixed or fresh tissue sections, cells, and in vivo systemic injection. Available in five variants (480, 520, 540, 630, 680) specified by peak emission wavelength.
  • EbbaBiolight
  • Carbotrace

Products and services

  • Amytracker

Quantifiable outcome

  • Amytracker is 10x brighter than Congo Red and detects amyloid in 15% of Congo Red negative samples
  • +1 more outcomes

Companies that use Ebba Biotech AB

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Ebba Biotech AB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ebba Biotech AB partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Karolinska Institutet (AIMES - Center for the Advancement of Integrated Medical and Engineering Sciences)coreStrategic or Co-development PartnerEbba Biotech was co-founded by researchers from Karolinska Institutet. Co-founder Ferdinand X. Choong is Team Leader at AIMES, and founder Prof. Agneta Richter-Dahlfors is Professor at Karolinska Institutet. AIMES is a joint center funded by KTH Royal Institute of Technology and Karolinska Institutet, promoting interdisciplinary research. Multiple publications and testimonials cite research conducted at AIMES using Ebba Biotech products, indicating ongoing collaborative R&D relationship.
  • reMYND (InnoSer)minorStrategic or Co-development PartnerreMYND is a Contract Research Organization that has integrated Amytracker 520 into its preclinical research protocols for Alzheimer's and Parkinson's disease mouse models. Their Science Director, Tom Cornelissen, provided a testimonial highlighting the exceptional results with Amytracker 520 for detecting pathological features in brain tissue.
  • InscopixminorStrategic or Co-development PartnerInscopix, a company developing miniaturized microscopes (nVista miniscope) for in vivo brain imaging, has incorporated Amytracker 520 into their platform. Senior Research Scientist Shan Huang provided a testimonial noting Amytracker 520's exceptional performance for labeling A-beta plaques in vivo in 5xFAD mice with high signal-to-noise and efficient blood-brain barrier crossing.
  • Cytacoat ABminorStrategic or Co-development PartnerCytacoat AB, in collaboration with Karolinska Institutet and University of Southampton, used EbbaBiolight as part of research developing LubriShield, a novel anti-fouling coating for urinary catheters to prevent biofilm-related infections.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Ebba Biotech AB competitors and assessment

Company assessment

Direct peers

  • Biotium: Biotium (now part of Abcam) develops fluorescent dyes and probes for life science research, including protein aggregate and cell biology stains. It is a direct comparable in size, focus, and distribution model (e-commerce + distributors), making it the closest peer to Ebba Biotech's optotracer reagent business.
  • Lumiprobe: Lumiprobe manufactures specialty fluorescent dyes for biology and diagnostics, including reactive dyes and protein labels sold through e-commerce globally. Comparable as a similarly-sized fluorescent-probe specialist with a similar online + distributor go-to-market.
  • ATTO-Tec: ATTO-Tec develops high-performance fluorescent dyes used in microscopy, flow cytometry, and bioanalytics. Comparable as a specialty dye manufacturer targeting similar imaging and life-science research customers as Ebba Biotech.
  • StressMarq Biosciences: StressMarq supplies amyloid reagents, recombinant proteins, and antibodies for neurodegeneration research. Directly comparable product overlap with Ebba's Amytracker line for Alzheimer's, Parkinson's, and prion research.
  • AnaSpec (Eurofins): AnaSpec (now part of Eurofins) provides custom peptides, fluorescent probes, and amyloid research reagents. Direct overlap with Ebba Biotech's amyloid and protein-aggregate detection product line and similar customer base.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher's Life Science Solutions division sells an extensive catalog of fluorescent reagents, amyloid stains, and protein-aggregate detection kits under the Invitrogen and Thermo Scientific brands. A broad incumbent with overlapping capabilities rather than a niche competitor.
  • Bio-Techne: Bio-Techne (including R&D Systems and Tocris) offers proteins, antibodies, and small-molecule probes for neuroscience and cell biology. Overlaps with Ebba Biotech through reagents targeting protein aggregation and neurodegenerative disease research.
  • Merck (Sigma-Aldrich): Merck's life science division (Sigma-Aldrich, Millipore) distributes a broad catalog of fluorescent dyes, including thioflavin variants and Congo Red used as benchmark amyloid stains. Comparable as the dominant incumbent against whose legacy dyes Ebba Biotech competes.
  • Abcam (Danaher): Abcam, now part of Danaher, supplies antibodies and reagents for protein research, including antibodies targeting amyloid aggregates. Comparable as a broad incumbent serving the same academic and industry neuroscience customers as Ebba Biotech.
  • Li-Cor Biosciences: Li-Cor develops infrared fluorescent dyes and imaging systems for Western blots, microscopy, and in vivo imaging. Comparable as a specialty fluorescent-probe and imaging company with overlapping applications in protein-aggregate detection workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Ebba Biotech AB social profiles

Digital presence

Ebba Biotech AB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ebba Biotech AB leadership team

Management profile

Number of profiles

Profiles3 records

Ebba Biotech AB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ebba Biotech AB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ebba Biotech AB

What does Ebba Biotech AB do?

Ebba Biotech AB develops and commercializes fluorescent optotracer reagents based on luminescent conjugated oligothiophenes (LCOs) for visualizing biological nanostructures in research applications. The portfolio comprises three product lines: Amytracker (protein aggregate/amyloid detection), EbbaBiolight (bacterial and biofilm imaging), and Carbotrace (carbohydrate analysis), sold in multiple spectral variants and formulations. A laboratory-based Carbotrace Testing Service is also offered to assist customers with sample analysis and product selection.

Is Ebba Biotech AB a public or private company?

Ebba Biotech AB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ebba Biotech AB founded?

Ebba Biotech AB was founded in 2015. It employs 1 to 10 people.

Where is Ebba Biotech AB based?

Ebba Biotech AB is headquartered in Solna, Sweden, in the Europe region.

How does Ebba Biotech AB make money?

Two revenue lines are on record. Product sales - Amytracker, EbbaBiolight, Carbotrace is the primary driver. The others are carbotrace Testing Service.

Who are Ebba Biotech AB's main competitors?

Direct peers on record are Biotium, Lumiprobe, ATTO-Tec, StressMarq Biosciences and AnaSpec (Eurofins). Broad incumbents are Thermo Fisher Scientific, Bio-Techne, Merck (Sigma-Aldrich), Abcam (Danaher) and Li-Cor Biosciences.

Does Ebba Biotech AB have an API?

No public API is recorded for Ebba Biotech AB.

What industry is Ebba Biotech AB in?

Ebba Biotech AB's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales